Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.

about

Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Children and Young Adults with Relapsed Ewing's Sarcoma: A Systematic Review.

P2860

Q55050439-923D2741-6BA1-4F59-872C-2E963A5316AC Q55426535-BC833E37-CFDC-4CE3-83D1-76B5B5E4B5B9

P2860

Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.

Item

http://www.wikidata.org/entity/Q38666300

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Salvage treatment for testicul ...... stematic review of 59 studies.

@en

type

Item

label

Salvage treatment for testicul ...... stematic review of 59 studies.

@en

prefLabel

Salvage treatment for testicul ...... stematic review of 59 studies.

@en

P1476

Salvage treatment for testicul ...... ystematic review of 59 studies

@en

P2093

Andrea Coinu

http://www.w3.org/2001/XMLSchema#string

Giovanni Rosti

http://www.w3.org/2001/XMLSchema#string

Sandro Barni

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care--Registry data from an outcomes research project of the German Testicular Cancer Study Group.

Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.

Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes.

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.

Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

P2888

s12032-017-0990-6

P304

133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S12032-017-0990-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P Pedrazzoli

Fausto Petrelli

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086370028

http://www.w3.org/2001/XMLSchema#string

P698

28653284

http://www.w3.org/2001/XMLSchema#string

Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.

about

P2860

P2860

Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698